GK01 cell therapy for advanced lung or esophageal cancer
Treatments studied
This trial tests a new cell treatment called GK01 for people with advanced lung cancer or esophageal cancer that has not responded to standard treatments. The study aims to see if this therapy can help shrink tumors or slow the cancer's growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have advanced lung cancer or esophageal squamous cell cancer that has not gotten better with standard treatments.
- You need to have at least one tumor that can be measured on a scan and has not been treated with radiation or other local therapies.
- You should be in fairly good health, able to take care of yourself, and have an expected survival of more than 3 months.
- You must have adequate blood cell counts and organ function, and no major health issues like uncontrolled infections, autoimmune diseases, or heart problems.
- You cannot have had other cancer treatments within 28 days before starting this study, and any side effects from past treatments must have mostly gone away.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental cell treatment called GK01 for people with advanced solid tumors that have stopped responding to standard therapies. The goal is to see if it can help shrink tumors or slow their growth.
This trial tests a new drug called GK01 in patients with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective, and may be an option for those who can have a tumor surgically removed.
This trial tests an injection of your own immune cells (tumor-infiltrating lymphocytes) to see if they can fight advanced solid tumors like stomach or lung cancer. Doctors will remove one of your tumors, grow the immune cells from it, and then give them back to you.
This early-stage trial tests KXV01, a personalized cancer treatment made from your own immune cells, for advanced solid tumors that have not responded to standard treatment. The goal is to see if it can help control your cancer and learn about its safety.
This trial tests a personalized cell therapy that uses your own immune cells (T-cells) specially modified to target your tumor. It is for people with advanced solid tumors who have run out of standard treatment options.
This trial tests a new cell therapy called GK01 for people with advanced lung cancer that has worsened after standard treatments. It aims to see if this treatment can help shrink tumors or slow the cancer's growth.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.